The causes and consequences of seasonal variation in COPD exacerbations

International Journal of COPD

Volumn 9, Issue , 2014, Pages 1101-1110

  Donaldson, Gavin C ^a   Wedzicha, Jadwiga A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Exacerbations of COPD; Seasonality; Winter morbidity; Winter mortality

Indexed keywords

VITAMIN D;

ARTICLE; CAUSAL ATTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLIMATE; COLD; COMORBIDITY; DISEASE EXACERBATION; ENVIRONMENTAL EXPOSURE; HOSPITAL ADMISSION; HOUSING; HUMAN; HUMAN RHINOVIRUS; INFECTION SENSITIVITY; LATITUDE; MORTALITY; NONHUMAN; PEAK EXPIRATORY FLOW; PRIMARY MEDICAL CARE; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY VIRUS; SEASONAL VARIATION; SELF REPORT; SUMMER; TROPICS; VIRAL RESPIRATORY TRACT INFECTION; WINTER; DISEASE COURSE; HOSPITALIZATION; LUNG; PATHOPHYSIOLOGY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SEASON; TIME FACTOR; WEATHER;

DISEASE PROGRESSION; HOSPITALIZATION; HUMANS; LUNG; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEASONS; TIME FACTORS; WEATHER;

EID: 84907854054     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S54475     Document Type: Article

References (77)

1. Aaron SD, Donaldson G., Whitmore GA, Hurst JR, Ramsay T, Wedzicha JA. Time course and pattern of COPD exacerbation onset. Thorax. 2012;67(3):238-243.
2. Donaldson G., Wedzicha JA. COPD exacerbations. 1: Epidemiology. Thorax. 2006;61(2):164-168.
3. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196-204.
4. National Clinical Guideline Centre. Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. London: National Clinical Guideline Centre; 2010. http://guidance.nice.org.uk/CG101/Guidance/pdf/English. Accessed August 4, 2014.
5. Wedzicha JA, Seemungal TA, MacCallum PK, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost. 2000;84(2):210-215.
6. Hurst J, Donaldson G., Perera WR, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174(8):867-874.
7. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000;55(2):114-120.
8. Garcia-Gutierrez S, Quintana JM, Barrio I, et al. Application of appropriateness criteria for hospitalization in COPD exacerbation. Intern Emerg Med. 2013;8(4):349-357.
9. Calderon-Larranaga A, Carney L, Soljak M, et al. Association of population and primary healthcare factors with hospital admission rates for chronic obstructive pulmonary disease in England: national cross-sectional study. Thorax. 2011;66(3):191-196.
10. Organisation for Economic Co-operation and Development. Health at a Glance 2011: OECD Indicators. Paris: OECD; 2011. Available from: http://dx.doi.org/10.1787/health_glance-2011-en. Accessed August 4, 2014.
11. Jenkins CR, Celli B, Anderson JA, et al. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J. 2012;39(1):38-45.
12. Rabe KF, Fabbri LM, Vogelmeier C, et al. Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial. Chest. 2013;143(3):711-719.
13. Donaldson G., Seemungal T, Jeffries DJ, Wedzicha JA. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J. 1999;13(4):844-849.
14. Donaldson G., Goldring JJ, Wedzicha JA. Influence of season on exacerbation characteristics in patients with COPD. Chest. 2012;141(1): 94-100.
15. Johnston NW, McIvor A, Lambert K, et al. The Christmas season as a risk factor for chronic obstructive pulmonary disease exacerbations. Can Respir J. 2010;17(6):275-281.
16. Seemungal TA, Donaldson G., Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418-1422.
17. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59(5):387-395.
18. Quint JK, Baghai-Ravary R, Donaldson G., Wedzicha JA. Relationship between depression and exacerbations in COPD. Eur Respir J. 2008;32(1):53-60.
19. Singh SJ, Sewell L, Williams JE, Morgan MD. Seasonal variations in exercise tolerance, activity and quality of life in patients with chronic obstructive pulmonary disease (COPD). Poster presented at: 15th Annual Congress of the European Respiratory Society; September 17-21, 2005; Copenhagen, Denmark.
20. Public Health England. Cold Weather Plan for England 2013: Protecting Health and Reducing Harm from Cold Weather. London: Public Health England; 2013. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/252838/Cold_Weather_Plan_2013_final.pdf. Accessed August 4, 2014.
21. Anderson HR, Spix C, Medina S, et al. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J. 1997;10(5): 1064-1071.
22. Ballester F, Pérez-Hoyos S, Rivera ML, et al. [The patterns of use and factors associated with the patient admission of hospital emergencies for asthma and chronic obstructive pulmonary disease]. Arch Bronconeumol. 1999;35(1):20-26. Spanish.
23. Vilkman S, Keistinen T, Tuuponen T, Kivelä SL. Seasonal variation in hospital admissions for chronic obstructive pulmonary disease in Finland. Arctic Med Res. 1996;55(4):182-186.
24. Monteiro A, Carvalho V, Góis J, Sousa C. Use of “Cold Spell” indices to quantify excess chronic obstructive pulmonary disease (COPD) morbidity during winter (November to March 2000-2007): case study in Porto. Int J Biometeorol. 2013;57(6):857-870.
25. Brims FJ, Asiimwe A, Andrews NP, et al. Weekend admission and mortality from acute exacerbations of chronic obstructive pulmonary disease in winter. Clin Med. 2011;11(4):334-339.
26. Mapel DW, Dedrick D, Davis K. Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999. COPD. 2005;2(1):35-41.
27. Lim YH, Hong YC, Kim H. Effects of diurnal temperature range on cardiovascular and respiratory hospital admissions in Korea. Sci Total Environ. 2012;417-418:55-60.
28. Ko FW, Tam W, Wong TW, et al. Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong. Thorax. 2007;62(9):780-785.
29. Upshur RE, Moineddin R, Crighton E, Kiefer L, Mamdani M. Simplicity within complexity: seasonality and predictability of hospital admissions in the province of Ontario 1988-2001, a population-based analysis. BMC Health Serv Res. 2005;5(1):13.
30. Marno P, Chalder M, Laing-Morton T, Levy M, Sachon P, Halpin D. Can a health forecasting service offer COPD patients a novel way to manage their condition? J Health Serv Res Policy. 2010;15(3): 150-155.
31. Bryden C, Bird W, Titley HA, Halpin D., Levy ML. Stratification of COPD patients by previous admission for targeting of preventative care. Respir Med. 2009;103(4):558-565.
32. Jordan RE, Hawker JI, Ayres JG, et al. Effect of social factors on winter hospital admission for respiratory disease: a case-control study of older people in the UK. Br J Gen Pract. 2008;58(551):400-402.
33. McAllister DA, Morling JR, Fischbacher CM, MacNee W, Wild SH. Socioeconomic deprivation increases the effect of winter on admissions to hospital with COPD: retrospective analysis of 10 years of national hospitalisation data. Prim Care Respir J. 2013;22(3): 296-299.
34. Kinnunen T, Säynäjäkangs O, Tuuponen T, Keistinen T. Regional and seasonal variation in the length of hospital stay for chronic obstructive pulmonary disease in Finland. Int J Circumpolar Health. 2002;61(2):131-135.
35. Walker GE, Lee C, Elkin SL. Seasonality and attendance at a pulmonary rehabilitation programme. Thorax. 2011;66(7):634-635.
36. Moineddin R, Nie JX, Domb G, Leong AM, Upshur RE. Seasonality of primary care utilization for respiratory diseases in Ontario: a time-series analysis. BMC Health Serv Res. 2008;8:160.
37. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. Respir Care. 2002;47(10):1184-1199.
38. Wilkinson P, Pattenden S, Armstrong B, et al. Vulnerability to winter mortality in elderly people in Britain: population based study. BMJ. 2004;329(7467):647.
39. Wordley J, Walters S, Ayres JG. Short term variations in hospital admissions and mortality and particulate air pollution. Occup Environ Med. 1997;54(2):108-116.
40. Kelsall JE, Samet JM, Zeger SL, Xu J. Air pollution and mortality in Philadelphia, 1974-1988. Am J Epidemiol. 1997;146(9):750-762.
41. Donaldson G., Keatinge WR. Early increases in ischaemic heart disease mortality dissociated from and later changes associated with respiratory mortality after cold weather in south east England. J Epidemiol Community Health. 1997;51(6):643-648.
42. Group TE. Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. The Eurowinter Group. Lancet. 1997;349(9062):1341-1346.
43. Donaldson G., Tchernjavskii VE, Ermakov SP, Bucher K, Keatinge WR. Winter mortality and cold stress in Yekaterinburg, Russia: interview survey. BMJ. 1998;316(7130):514-518.
44. Donaldson G., Ermakov SP, Komarov YM, McDonald CP, Keatinge WR. Cold related mortalities and protection against cold in Yakutsk, eastern Siberia: observation and interview study. BMJ. 1998;317(7164):978-982.
45. Thomson H, Petticrew M, Morrison D. Health effects of housing improvement: systematic review of intervention studies. BMJ. 2001;323(7306):187-190.
46. Howden-Chapman P, Pierse N, Nicholls S, et al. Effects of improved home heating on asthma in community dwelling children: randomised controlled trial. BMJ. 2008;337:a1411.
47. Howden-Chapman P, Matheson A, Crane J, et al. Effect of insulating existing houses on health inequality: cluster randomised study in the community. BMJ. 2007;334(7591):460.
48. Keatinge W, Donaldson G. Winter deaths: warm housing is not enough. BMJ. 2001;323(7305):166-167.
49. Keatinge WR. Seasonal mortality among elderly people with unrestricted home heating. Br Med J (Clin Res Ed). 1986;293(6549):732-733.
50. Osman LM, Ayres JG, Garden C, Reglitz K, Lyon J, Douglas JG. Home warmth and health status of COPD patients. Eur J Public Health. 2008;18(4):399-405.
51. Ko FW, Ip M, Chan PK, et al. Viral etiology of acute exacerbations of COPD in Hong Kong. Chest. 2007;132(3):900-908.
52. McManus TE, Marley AM, Baxter N, et al. Respiratory viral infection in exacerbations of COPD. Respir Med. 2008;102(11):1575-1580.
53. Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit care Med. 2001;164(9):1618-1623.
54. Beckham JD, Cadena A, Lin J, et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect. 2005;50(4):322-330.
55. Rohde G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003;58(1):37-42.
56. Monto AS. Epidemiology of viral respiratory infections. Am J Med. 2002;112 Suppl 6A:4S-12S.
57. Monto AS. The seasonality of rhinovirus infections and its implications for clinical recognition. Clin Ther. 2002;24(12):1987-1997.
58. Mäkinen TM, Juvonen R, Jokelainen J, et al. Cold temperature and low humidity are associated with increased occurrence of respiratory tract infections. Respir Med. 2009;103(3):456-462.
59. Johnson C, Eccles R. Acute cooling of the feet and the onset of common cold symptoms. Fam Pract. 2005;22(6):608-613.
60. Dowling HF, Jackson GG, Spiesman IG, Inouye T. Transmission of the common cold to volunteers under controlled conditions. III. The effect of chilling of the subjects upon susceptibility. Am J Hyg. 1958;68(1):59-65.
61. Eccles R. An explanation for the seasonality of acute upper respiratory tract viral infections. Acta Otolaryngol. 2002;122(2):183-191.
62. Tang JW. The effect of environmental parameters on the survival of airborne infectious agents. J R Soc Interface. 2009;6 Suppl 6: S737-S746.
63. Yang W, Elankumaran S, Marr LC. Relationship between humidity and influenza a viability in droplets and implications for influenza’s seasonality. PloS One. 2012;7(10):e46789.
64. Shaman J, Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. Proc Natl Acad Sci U S A. 2009;106(9):3243-3248.
65. Hutchinson AF, Thompson MA, Clark L, Irving LB. Communicating information regarding human H1N1-09 virus to high-risk consumers: knowledge and understanding of COPD patients in Melbourne, Australia. Collegian. 2010;17(4):199-205.
66. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7(10):658-666.
67. Thijs C, Beyer WE, Govaert PM, Sprenger MJ, Dinant GJ, Knottnerus A. Mortality benefits of influenza vaccination in elderly people. Lancet Infect Dis. 2008;8(8):460-461; author reply 463-465.
68. Kelly H, Newall AT. Mortality benefits of influenza vaccination in elderly people. Lancet Infect Dis. 2008;8(8):462-463; author reply 463-465.
69. Voordouw BC, Sturkenboom MC, Dieleman JP, Stricker BH. Mortality benefits of influenza vaccination in elderly people. Lancet Infect Dis. 2008;8(8):461-462; author reply 463-465.
70. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people-authors’ reply. Lancet Infect Dis. 2008;8(8):463-465.
71. Wedzicha JA, Seemungal TA, MacCallum PK, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost. 2000;84(2):210-215.
72. Turner RB, Fuls JL, Rodgers ND, Goldfarb HB, Lockhart LK, Aust LB. A randomized trial of the efficacy of hand disinfection for prevention of rhinovirus infection. Clin Infect Dis. 2012;54(10):1422-1426.
73. Quint JK, Donaldson G., Wassef N, Hurst JR, Thomas M, Wedzicha JA. 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease. BMC Pulm Med. 2012;12:28.
74. Puhan MA, Siebeling L, Frei A, Zoller M, Bischoff-Ferrari H, ter Riet G. NO association of 25-hydroxyvitamin D with exacerbations in primary care patients with COPD. Chest. 2014;145(1):37-43.
75. Donaldson G., Keatinge WR. Mortality related to cold weather in elderly people in southeast England, 1979-1994. BMJ. 1997;315(7115): 1055-1056.
76. Christidis N, Donaldson G, Stott PA. Causes for the recent changes in cold-and heat-related mortality in England and Wales. Clim Change. 2010;102(3-4):539-553.
77. Respiratory infections: laboratory reports 2014 [homepage on the internet]. Public Health England; 2014 [updated September 5, 2014]. Available from: https://www.gov.uk/government/publications/respiratory-infections-laboratory-reports-2014. Accessed September 24, 2014. Contains public sector information licensed under the Open Government Licence v2.0.